Global RWE Strategy Leader, Immunology

UCB; Brussel; Hybrid; EUR 110,000 - 140,000; Full time

Benefits offered by this job

Hybrid work model

Global exposure

Job summary

UCB, a global biopharmaceutical company, seeks a strategic RWE Leader for Developed Brands in Immunology. You will design and drive real-world evidence programs across the product lifecycle, partnering with Medical Affairs, Clinical Development, HEOR, and Market Access to inform regulatory and payer decisions.

You will identify evidence gaps, lead complex studies, and guide decisions with data-driven insights, using advanced methods and AI-enabled approaches to improve patient impact.

Qualifications

• 8+ years in pharma/biotech/healthcare with evidence generation and payer initiatives.
• Strong understanding of RWE, epidemiology, outcomes research, and healthcare data sources.
• Experience developing evidence strategies for regulatory, reimbursement, and business decisions.
• Ability to lead complex initiatives and influence stakeholders.

Responsibilities

• Develop and co lead integrated real-world evidence (RWE), epidemiology, outcomes research, and data strategies that support UCB's assets across the product lifecycle.
• Identify evidence gaps and define research plans that address regulatory, market access, reimbursement, safety, and patient-centered evidence needs.
• Shape evidence-generation strategies using real-world data, registries, external control arms, innovative study designs, and other fit-for-purpose methodologies.
• Anticipate evolving scientific, regulatory, and business challenges and translate them into actionable evidence solutions and investments.
• Oversee the execution of RWE studies and programs, ensuring delivery on time, within budget, and in accordance with quality and governance standards.
• Drive alignment across complex evidence-generation activities, balancing the needs of multiple stakeholders while maximizing impact and efficiency.
• Provide strategic guidance on disease burden, natural history, comparative effectiveness, long-term outcomes, drug utilization, safety commitments, and HTA requirements.
• Leverage emerging technologies, including AI-enabled approaches, to enhance data strategy, evidence generation, and decision-making.
• Mentor and develop RWE talent while contributing to growth of evidence-generation capabilities.
• Represent UCB externally through engagement with scientific experts, research partners, and industry initiatives.

Skills

RWE strategy

Epidemiology

Outcomes research

Big Data

AI experience

Education

Master's degree

Job description

UCB, a global biopharmaceutical company, seeks a strategic RWE Leader for Developed Brands in Immunology. You will design and drive real-world evidence programs across the product lifecycle, partnering with Medical Affairs, Clinical Development, HEOR, and Market Access to inform regulatory and payer decisions.

You will identify evidence gaps, lead complex studies, and guide decisions with data-driven insights, using advanced methods and AI-enabled approaches to improve patient impact.